首页> 外国专利> Angle of diffraction (20.1) the below-mentioned formula which shows diffraction peak in the 7.1, the 9.9, the 12.1, the 14.2, the 15.5, the 16.4, the 17.7 and the 21.7 the 1,3,5 which is shown with

Angle of diffraction (20.1) the below-mentioned formula which shows diffraction peak in the 7.1, the 9.9, the 12.1, the 14.2, the 15.5, the 16.4, the 17.7 and the 21.7 the 1,3,5 which is shown with

机译:衍射角(20.1)表示在7.1、9.9、12.1、14.2、15.5、16.5、16.4、17.7和21.7的衍射峰的下述式所示的1、3、5。

摘要

PROBLEM TO BE SOLVED: To provide a crystalline 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-di-methylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione, having good handleability such as workability in use and generating less dust and to provide a production method and use thereof.;SOLUTION: The crystalline 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-di-methylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione, a compound represented by formula (1), exhibits diffraction peaks at diffraction angles (20.1) of 7.1, 9.9, 12.1, 14.2, 15.5, 16.4, 17.7, and 21.7 in powder X-ray diffraction analysis with Cu-K rays. The method for producing the compound, an antioxidant containing the compound and a resin composition or a resin molded product containing the antioxidant are also provided.;COPYRIGHT: (C)2004,JPO
机译:解决的问题:提供结晶的1,3,5-三(4-叔丁基-3-羟基-2,6-二甲基苄基)-1,3,5-三嗪-2,4,6- (1H,3H,5H)-三酮,具有良好的可操作性,例如使用中的可加工性,并产生较少的粉尘,并提供其生产方法和用途。由式(1)表示的化合物-3-羟基-2,6-二甲基苄基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮显示出衍射峰在使用Cu-K射线进行粉末X射线衍射分析时,衍射角(20.1)分别为7.1、9.9、12.1、14.2、15.5、16.4、17.7和21.7。还提供了该化合物的制备方法,包含该化合物的抗氧化剂和包含该抗氧化剂的树脂组合物或树脂成型品。版权所有:(C)2004,JPO

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号